Abstract:BackgroundThyroid tissue has a special immune microenvironment that is not well characterized. Whether immune cells have a prognostic value in the recurrence of papillary thyroid cancer (PTC) needs further investigation.MethodsMultinodular non-toxic goiter (MNG) was taken as normal tissue for the difficulty in obtaining completely normal thyroid tissue (normal thyroid function, no thyroiditis, and no nodules). We compared the composition of mononuclear cells (MNCs) in peripheral blood and thyroid tissues from MNG and PTC patients by high-dimensional flow cytometry profiling and verified the results by multiplex immunohistochemistry. The recurrence rates of PTC patients with different CD8+T cell subset signatures were compared using TCGA database.ResultsWe observed that the immune cell composition of MNG was different from that in peripheral blood. Thyroid tissue contains higher percentages of T cells and NK cells. Moreover, the percentages of memory T cells and Treg cells were higher in thyroid than in peripheral blood and increased in PTC tumors. We further focused on the antitumoral CD8+T cells and found that the expression patterns of PD-1, CD39, and CD103 on CD8+T cells were different between MNG and PTC. Importantly, we found higher percentages of PD-1+CD39+CD103+CD8+T and PD-1+CD39+CD103-CD8+T cells in PTC tumor tissues from recurrent patients than non-recurrent patients. By analyzing PTC data from TCGA database, we found that the expression patterns of these molecules were associated with different pathologic types and genders among PTC patients. Moreover, patients with PD-1hiCD39loCD103hiCD8hi, PD-1hiCD39hiCD103loCD8hi, and PD-1loCD39hiCD103hiCD8hi expression patterns have a higher 10-year recurrence-free survival.ConclusionThe immune microenvironment in MNG tissue is distinct from that in peripheral blood and paratumor tissue. More memory CD8+T cells were detected in PTC, and expression patterns of PD-1, CD39, and CD103 on CD8+T cells were significantly different in physiology and gender and associated with the recurrence rate of PTC. These observations indicate that CD8+T cell signatures may be useful prognostic markers for PTC recurrence.

Clinicopathological Significance And Prognostic Value Of Nkx2.2 Expression In Papillary Thyroid Carcinoma

Impact of Lin28 on Lymph Node Metastasis in Papillary Thyroid Carcinoma

Immunohistochemistry related to the diagnosis and metastasis of papillary thyroid carcinoma

Quantitative proteomics analysis of papillary thyroid carcinoma reveals Protein S, Clusterin, and Leucine-rich α-2-glycoprotein 1 as potential prognostic protein biomarkers

Quantitative proteomics analysis of papillary thyroid carcinoma reveals PROS1, CLU, and LRG1 as potential novel prognostic protein biomarkers

Transition Analysis in the Clinicopathology and Prognosis of 2 682 Papillary Thyroid Carcinoma Cases over a 15-Year Period

Aberrant Kinesin Family Member 2A Signifies Tumor Size and Invasion, and May Help Predict Prognosis of Patients with Papillary Thyroid Carcinoma.

Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma

The Protein Expression and Clinical Significance of Coiled-Coil Domain Containing 67 and B Cell Lymphoma/leukemia-2 in Papillary Thyroid Carcinoma

Association of Xiap and P2x(7) Receptor Expression with Lymph Node Metastasis in Papillary Thyroid Carcinoma

Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence.

KLK7, KLK10, and KLK11 in Papillary Thyroid Cancer: Bioinformatic Analysis and Experimental Validation

AP-2α Expression in Papillary Thyroid Carcinoma Predicts Tumor Progression and Poor Prognosis

GCN2 is a potential prognostic biomarker for human papillary renal cell carcinoma.

MKL1 overexpression predicts poor prognosis in patients with papillary thyroid cancer and promotes nodal metastasis

Lipocalin-2 expression in papillary thyroid carcinoma and its association with clinicopathological characteristics

Prognostic impact of PTK6 expression in triple negative breast cancer

TPX 2 in Human Clear Cell Renal Carcinoma : Expression , Function and Prognostic Significance

SKP2 Contributes to AKT Activation by Ubiquitination Degradation of PHLPP1, Impedes Autophagy, and Facilitates the Survival of Thyroid Carcinoma.

Immune Profiling Identifies CD8+ T-cell Subset Signatures As Prognostic Markers for Recurrence in Papillary Thyroid Cancer

Correlation between genetic alterations and clinicopathological features of papillary thyroid carcinomas